Publications by authors named "Tom Greene"

359Publications

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.

Kidney Int 2020 Dec 11. Epub 2020 Dec 11.

Department of Renal and Metabolic, The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:

View Article and Find Full Text PDF
December 2020

Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.

Circulation 2020 Nov 13. Epub 2020 Nov 13.

The George Institute for Global Health, Sydney, Australia; Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

View Article and Find Full Text PDF
November 2020

Clinical predictors for etiology of acute diarrhea in children in resource-limited settings.

PLoS Negl Trop Dis 2020 10 9;14(10):e0008677. Epub 2020 Oct 9.

Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States of America.

View Article and Find Full Text PDF
October 2020

Dapagliflozin in Patients with Chronic Kidney Disease.

N Engl J Med 2020 10 24;383(15):1436-1446. Epub 2020 Sep 24.

From the Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.); the George Institute for Global Health, Sydney (H.J.L.H., D.C.W.); Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (B.V.S., M.L., C.D.S., A.-M.L.); the National Medical Science and Nutrition Institute Salvador Zubirán, Mexico City (R.C.-R.); the Departments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA (G.M.C.); the Study Design and Biostatistics Center, University of Utah Health Sciences, Salt Lake City (T.G.); the Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, Guangzhou, China (F.-F.H.); KfH Kidney Center, Munich, and Department of Medicine 4, University of Erlangen-Nuremberg, Erlangen - both in Germany (J.F.E.M.); the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow (J.J.V.M.), and the Department of Renal Medicine, University College London, London (D.C.W.) - both in the United Kingdom; Steno Diabetes Center Copenhagen, Gentofte, and the Department of Clinical Medicine, University of Copenhagen, Copenhagen - both in Denmark (P.R.); and the Department of Internal Medicine, UT Southwestern Medical Center, Dallas (R.D.T.).

View Article and Find Full Text PDF
October 2020

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.

Am J Kidney Dis 2020 12 5;76(6):842-850. Epub 2020 Aug 5.

Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.

View Article and Find Full Text PDF
December 2020